Role of Intestinal Cytochrome P450 (P450) in Modulating the Bioavailability of Oral Lovastatin: Insights from Studies on the Intestinal Epithelium-Specific P450 Reductase Knockout Mouse

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Drug Metabolism And Disposition

• Publication date

  2011-06-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1124/dmd.110.037861PMID 21349922PMCID PMC3100899
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The Role of Small-Intestinal P450 Enzymes in Protection against Systemic Exposure of Orally Administered Benzo[a]Pyrene

  2010cited by this paper
• An Intestinal Epithelium-Specific Cytochrome P450 (P450) Reductase-Knockout Mouse Model: Direct Evidence for a Role of Intestinal P450s in First-Pass Clearance of Oral Nifedipine

  2009cited by this paper
• Determination of lovastatin hydroxy acid in female B6C3F1 mouse serum.

  2008influential reference
• A rapid and specific approach for direct measurement of pravastatin concentration in plasma by LC-MS/MS employing solid-phase extraction.

  2007cited by this paper
• Knockout of cytochrome P450 3A yields new mouse models for understanding xenobiotic metabolism.

  2007cited by this paper
• THE HUMAN INTESTINAL CYTOCHROME P450 “PIE”

  2006cited by this paper
• Grapefruit‐Drug Interactions: Can Interactions With Drugs Be Avoided?

  2006cited by this paper
• DIFFERENTIAL INTERACTION OF 3-HYDROXY-3-METHYLGLUTARYL-COA REDUCTASE INHIBITORS WITH ABCB1, ABCC2, AND OATP1B1

  2005cited by this paper
• Chemical, pharmacokinetic and pharmacodynamic properties of statins: an update

  2005cited by this paper
• Predicting Drug Disposition via Application of BCS: Transport/Absorption/ Elimination Interplay and Development of a Biopharmaceutics Drug Disposition Classification System

  2004influential reference
• Effects of grapefruit juice and orange juice components on P‐glycoprotein‐ and MRP2‐mediated drug efflux

  2004cited by this paper
• Human extrahepatic cytochromes P450: function in xenobiotic metabolism and tissue-selective chemical toxicity in the respiratory and gastrointestinal tracts.

  2003cited by this paper
• Characterization of mouse small intestinal cytochrome P450 expression.

  2003cited by this paper
• The small intestine as a xenobiotic-metabolizing organ.

  2003cited by this paper
• The Mucosa of the Small Intestine

  2002cited by this paper
• A comparison of the effects of 3-hydroxy-3-methylglutaryl-coenzyme a (HMG-CoA) reductase inhibitors on the CYP3A4-dependent oxidation of mexazolam in vitro.

  2001cited by this paper
• Quantitative determination of pravastatin and its biotransformation products in human serum by turbo ion spray LC/MS/MS.

  2000cited by this paper
• Role of metabolic enzymes and efflux transporters in the absorption of drugs from the small intestine.

  2000cited by this paper
• 6′,7′‐Dihydroxybergamottin in grapefruit juice and Seville orange juice: Effects on cyclosporine disposition, enterocyte CYP3A4, and P‐glycoprotein

  1999cited by this paper
• Comparison of cytochrome P-450-dependent metabolism and drug interactions of the 3-hydroxy-3-methylglutaryl-CoA reductase inhibitors lovastatin and pravastatin in the liver.

  1999cited by this paper
• Is the role of the small intestine in first-pass metabolism overemphasized?

  1999cited by this paper
• Small intestinal metabolism of the 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitor lovastatin and comparison with pravastatin.

  1999cited by this paper
• Grapefruit juice greatly increases serum concentrations of lovastatin and lovastatin acid

  1998cited by this paper
• Grapefruit juice-drug interactions.

  1998influential reference
• Enzyme-catalyzed processes of first-pass hepatic and intestinal drug extraction.

  1997cited by this paper
• Comparative Evaluation of the Safety and Efficacy of HMG-CoA Reductase Inhibitor Monotherapy in the Treatment of Primary Hypercholesterolemia

  1995cited by this paper
• Rat small intestinal cytochromes P450 probed by warfarin metabolism.

  1993cited by this paper
• Biotransformation of lovastatin. IV. Identification of cytochrome P450 3A proteins as the major enzymes responsible for the oxidative metabolism of lovastatin in rat and human liver microsomes.

  1991cited by this paper
• Biotransformation of lovastatin. I. Structure elucidation of in vitro and in vivo metabolites in the rat and mouse.

  1990cited by this paper
• The physiological disposition of lovastatin.

  1989cited by this paper
• The Mucosa of the Small Intestine

  1961cited by this paper

• Mechanisms and implications of the gut microbial modulation of intestinal metabolic processes

  2025cites this paper
• Acute administration of lovastatin had no pronounced effect on motor abilities, motor coordination, gait nor simple cognition in a mouse model of Angelman syndrome

  2025influential citation
• The intestinal 3M (microbiota, metabolism, metabolome) Zeitgeist - from fundamentals to future challenges.

  2021cites this paper
• Pharmacogenomics and circadian rhythms as mediators of cardiovascular drug-drug interactions

  2021cites this paper
• Inter‐individual and inter‐regional variations in enteric drug metabolizing enzyme activities: Results with cryopreserved human intestinal mucosal epithelia (CHIM) from the small intestines of 14 donors

  2020cites this paper
• Pharmacogenetics of Statin-Induced Myotoxicity

  2020cites this paper
• Considerations for Clinical Therapeutic Development of Statins for Neurodevelopmental Disorders

  2020cites this paper
• An updated review of pharmacokinetic drug interactions and pharmacogenetics of statins

  2020cites this paper
• Hepatic and intestinal biotransformation gene expression and drug disposition in a dextran sulfate sodium-induced colitis mouse model

  2019cites this paper
• Modeling Liver Diseases Using Hepatic Cell Microarrays

  2018cites this paper
• Significance of neurexin and neuroligin polymorphisms in regulating risk of Hirschsprung’s disease

  2018cites this paper
• An update on the potential role of intestinal first-pass metabolism for the prediction of drug–drug interactions: the role of PBPK modeling

  2018cites this paper
• Polymer coating on a micropillar chip for robust attachment of PuraMatrix peptide hydrogel for 3D hepatic cell culture.

  2018cites this paper
• Effect of polymorphisms in CYP3A4, PPARA, NR1I2, NFKB1, ABCG2 and SLCO1B1 on the pharmacokinetics of lovastatin in healthy Chinese volunteers.

  2017cites this paper
• Physiologically based pharmacokinetic modeling revealed minimal codeine intestinal metabolism in first‐pass removal in rats

  2017cites this paper
• Bioavailability enhancement of a BCS IV compound via an amorphous combination product containing ritonavir

  2016cites this paper
• An update on the role of intestinal cytochrome P450 enzymes in drug disposition

  2016cites this paper
• Porous Silica-Supported Solid Lipid Particles for Enhanced Solubilization of Poorly Soluble Drugs

  2016cites this paper
• Dealing with the complex drug-drug interactions: towards mechanistic models.

  2015cites this paper
• Intestinal Epithelium–Specific Knockout of the Cytochrome P450 Reductase Gene Exacerbates Dextran Sulfate Sodium–Induced Colitis

  2015influential citation
• Novel Effects of Simvastatin on Uterine Fibroids: In vitro and Patient-Derived Xenograft Mouse Model Study

  2015cites this paper
• Novel effects of simvastatin on uterine fibroid tumors: in vitro and patient-derived xenograft mouse model study.

  2015cites this paper
• Regulation of Intestinal Cytochrome P450 Expression by Hepatic Cytochrome P450: Possible Involvement of Fibroblast Growth Factor 15 and Impact on Systemic Drug Exposure

  2014cites this paper
• Mice Deficient in Intestinal Epithelium Cytochrome P450 Reductase are Prone to Acute Toxin-induced Mucosal Damage

  2014cites this paper
• Effects of Aqueous Extract of Moringa ole ifera Seeds on Alloxan Induced Hyperglycemia

  2014cites this paper
• Synergistic role of self-emulsifying lipids and nanostructured porous silica particles in optimizing the oral delivery of lovastatin.

  2014cites this paper
• Combined Analysis of Pharmacokinetic and Efficacy Data of Preclinical Studies with Statins Markedly Improves Translation of Drug Efficacy to Human Trials

  2013cites this paper
• NADPH–Cytochrome P450 Oxidoreductase: Roles in Physiology, Pharmacology, and Toxicology

  2013cites this paper
• TRAM-34, a Putatively Selective Blocker of Intermediate-Conductance, Calcium-Activated Potassium Channels, Inhibits Cytochrome P450 Activity

  2013cites this paper
• Potential Biological Functions of Cytochrome P450 Reductase-dependent Enzymes in Small Intestine

  2012cites this paper
• Why we need proper PBPK models to examine intestine and liver oral drug absorption.

  2012cites this paper
• Role of Intestinal Cytochrome P450 Enzymes in Diclofenac-Induced Toxicity in the Small Intestine

  2012cites this paper
• NADPH – Cytochrome P 450 Oxidoreductase : Roles in Physiology , Pharmacology , and Toxicology

  2012cites this paper
• Commentary: Theoretical Predictions of Flow Effects on Intestinal and Systemic Availability in Physiologically Based Pharmacokinetic Intestine Models: The Traditional Model, Segregated Flow Model, and QGut Model

  2012cites this paper
• Extrahepatic Drug-Metabolizing Enzymes and Their Significance

  2012cites this paper
• In vitro and in vivo small intestinal metabolism of CYP3A and UGT substrates in preclinical animals species and humans: species differences

  2011cites this paper